Rifaximin Treatment in Bloating Predominant Functional Bowel Disorders | MicrobiomeTrials← Back to trialsNCT07522255
Rifaximin Treatment in Bloating Predominant Functional Bowel Disorders
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-04Est. Completion: 2027-10
Enrollment target: 78 participants Locations- Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok Noi, Bangkok, Thailand
Other microbiome trials you might be interested in
Colonoscopy PainAbdominal Distension
This randomized controlled trial evaluated whether a 30-minute foot bath with warm water (40-41°C) after colonoscopy red…
Kocaeli, Turkey (Türkiye)Completed May 2, 2024
Functional Dyspepsia
Functional dyspepsia (FD) is one of most common chronic gastrointestinal disorders. Several types of drugs were demonstr…
Lanzhou, ChinaCompleted Mar 31, 2025
Hiatal Hernia Large
Patients who underwent laparoscopic repair of large hiatal hernias and anterior fundoplication with mesh are examined fo…
Multiple LocationsCompleted Jan 31, 2027